UV Irradiation Does Not Genetically Alter Melanocytes

Home>
Specialties>
Dermatology>
Summary and Comment

UV Irradiation Does Not Genetically Alter Melanocytes

The effects of UV irradiation on melanocytes are not fully understood. Previous research has shown that UV irradiation leads to histologic changes reminiscent of melanoma in situ, such as intraepidermal melanocyte atypia, and increased numbers of single melanocytes above the dermal-epidermal junction. In addition, certain genetic changes are known to occur in atypical nevi, which are the presumptive precursor lesions of melanoma. In this study, researchers genetically analyzed irradiated nevi to look for similar DNA derangements in affected melanocytes.

Seven symmetrical, benign nevi were chosen for examination. Half of each nevus was shielded, and the other half was exposed to UV irradiation at four times the patient's minimal erythema dose. One week later, each nevus was removed and DNA was extracted. Probes for various loci associated with melanomas and melanoma precursors (1p, 9q, and 9p21) were applied to treated and untreated nevi. No allelic losses were found in any of the nevi. The researchers concluded that, although the histologic changes in melanocytic nevi after UV exposure resemble melanoma in situ, they are not followed by similar alterations in melanocytic DNA.

Comment: As the researchers suggest, the one-week time interval between UV exposure and DNA examination may not have been sufficient for loss of genetic heterozygosity, and the irradiation doses may not have been large enough to induce detectable changes. It is also possible that the changes in melanocytes induced by UV exposure are transient and do not lead to permanent genetic alterations.

— BR Smoller

Published in Journal Watch Dermatology September 1, 1998

Citation(s):

Böni R et al. Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss. Arch Dermatol 1998 134 853-856.

Original article (Subscription may be required)
Medline abstract (Free)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.